Can MRI Scans Predict and Prevent Trismus After Oral Cancer Treatment?
"New research uses MRI to forecast trismus severity, offering hope for personalized treatment plans and better patient outcomes."
Trismus, or the restricted opening of the mouth, is a common and debilitating side effect for individuals undergoing treatment for head and neck cancers. Radiation therapy, while effective in targeting cancerous cells, can also damage the surrounding tissues, leading to stiffness and reduced mobility in the jaw. This condition significantly impacts a patient's ability to eat, speak, and maintain proper oral hygiene, thereby diminishing their overall quality of life.
Intensity-modulated radiation therapy (IMRT) is an advanced technique designed to minimize damage to healthy tissues during cancer treatment. However, even with IMRT, trismus remains a significant concern for many patients. Predicting which individuals are most likely to develop severe trismus and identifying strategies to mitigate this risk are critical challenges in oncology today.
Now, a new study offers a promising step forward. Researchers have explored the potential of magnetic resonance imaging (MRI) to predict the severity and prognosis of trismus in oral cancer patients undergoing IMRT. By identifying early MRI indicators, clinicians may be able to tailor treatment plans and implement preventive measures to reduce the impact of this challenging side effect.
Clinical Burden and MRI Prediction
A study followed 22 postoperative oral cancer patients who received adjuvant intensity-modulated radiation therapy (IMRT) over two years to develop MRI indicators for predicting trismus outcomes. Trismus is described as a debilitating complication of multimodal oral cancer treatment that affects quality of life and functional recovery. Preoperative trismus was most prevalent in tumors involving the buccal mucosa, retromolar trigone, and tongue, with a statistically significant association with anatomical subsite.
From Symptom to Survivorship Concern
Trismus has been recognized as more than a treatment-related adverse event: a 2026 review describes it as a survivorship burden affecting nutrition, communication, oral hygiene, and quality of life. In head and neck cancer, restricted mouth opening may present with malignancy, result from tumor location or growth, follow oncologic treatment, or signal tumor recurrence. One review defines trismus as reduced movement of the muscles of mastication that prevents mouth opening beyond 35 mm.
MRI as a Crystal Ball: Predicting Trismus Severity
The study, published in PLOS One, followed 22 oral cancer patients treated with IMRT over two years. The researchers used a scoring system based on MRI scans to assess abnormalities in the masticator muscles (responsible for chewing) and related structures. These "SA scores" were then compared with the patients' trismus grades.
- Correlation Confirmed: The study found a significant correlation between MRI-based signal abnormality (SA) scores and the severity of trismus (r=0.52, p<0.005).
- Dose Matters: Higher radiation doses to key structures like masticator and lateral pterygoid muscles, and the parotid gland, were linked to progressive trismus (p<0.05).
- Early Indicators: Higher SA-masticator muscle dose product at 6 months and SA scores at 12 months were also predictive of trismus progression (p<0.05).
MRI Texture Analysis
An MRI-based approach investigated 24 image textures to quantify radiation-induced normal-tissue injuries associated with trismus in head and neck cancer. One texture described the ratio between mean intensity and variance within local image patches. The study also monitored gadolinium uptake, linking the texture result with qualitatively observed increased intensity on post-contrast T1-weighted MRI scans.
Limited Early Evidence
The MRI evidence base includes a previous retrospective study of 35 nasopharyngeal carcinoma patients who had completed radiotherapy and developed trismus. In that study, trismus was defined using a dental gap of less than 2.5 cm. Because this evidence came from a retrospective analysis in nasopharyngeal carcinoma, it does not by itself establish that MRI can reliably predict trismus outcomes for every oral cancer population.
Dose, Exercise, and Rehabilitation
One report noted trismus incidences as high as 45% when masseter or pterygoid muscle doses exceeded 55 Gy. Prophylactic exercise interventions have been studied as a way to prevent trismus and difficulty opening the mouth, while a 2024 review states that standards for mouth-opening exercises remain unclear. Together, these sources frame MRI-based risk assessment as one approach that can be compared with dose-based risk information and preventive rehabilitation.
A Personalized Approach to Trismus Management
These findings pave the way for a more personalized approach to trismus management in oral cancer patients. By using MRI to assess the risk of trismus, clinicians can tailor radiation therapy plans to minimize damage to critical structures. For patients identified as high-risk, early intervention strategies such as physical therapy and jaw exercises can be implemented to prevent the development of severe trismus.
The study also highlights the importance of long-term monitoring for trismus. Regular MRI scans can help track changes in the masticator muscles and identify patients who may benefit from more aggressive interventions, such as Botox injections or surgery.
While further research is needed to validate these findings, this study represents a significant step forward in our understanding of trismus and its management. By combining MRI imaging with careful monitoring of radiation doses, clinicians can work to improve the quality of life for oral cancer patients undergoing treatment.